The 2nd prize award-winning paper, “The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment by Fred McElwee, PhD and Anthony T. Newall, PhD evaluates the importance of flexible vaccine manufacturing in responding to health threats. The authors identify key value drivers, develop estimation methods, and discuss integrating this value into HTA. They highlight the need for accurate tools to measure this flexibility and propose various methodologies to address this gap.
